Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study

BACKGROUND: The purpose of this study was to analyze the efficacy and safety of concurrent chemoradiotherapy combined with Nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma (NPC). METHODS: This study included 49 low-risk T4 stage NPC patients treated with concurrent chemoradiotherapy plus N...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuai, huang, Xiaopeng, Zhou, Liya, Lin, Shaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160225/
https://www.ncbi.nlm.nih.gov/pubmed/30235761
http://dx.doi.org/10.1097/MD.0000000000012503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160225/
https://www.ncbi.nlm.nih.gov/pubmed/30235761
http://dx.doi.org/10.1097/MD.0000000000012503

Ejemplares similares